Glutamine suppresses Hsp72 not Hsp90α and is not inducing Th1, Th2, or Th17 cytokine responses in human septic PBMCs

Nutrition

Volumn 30, Issue 10, 2014, Pages 1185-1194

  Briassouli, Efrossini ^a   Goukos, Dimitris ^a   Daikos, George ^a   Apostolou, Kleovoulos ^a   Routsi, Christina ^a   Nanas, Serafim ^a   Briassoulis, George ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Cytokines; Glutamine; Heat shock protein 72; Heat shock protein 90 ; Lipopolysaccharide; Peripheral blood mononuclear cells; Severe sepsis

Indexed keywords

ALANINE; GAMMA INTERFERON; GLUTAMINE; HEAT SHOCK PROTEIN 72; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 ALPHA; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG; ALANYLGLUTAMINE; CYTOKINE; DIPEPTIDE; HEAT SHOCK PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DISEASE SEVERITY; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; TH1 CELL; TH17 CELL; TH2 CELL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; MONONUCLEAR CELL;

CYTOKINES; DIPEPTIDES; GLUTAMINE; HEAT-SHOCK PROTEINS; HSP72 HEAT-SHOCK PROTEINS; HUMANS; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; SEPSIS; TH1 CELLS; TH17 CELLS; TH2 CELLS;

EID: 84926256784     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2014.01.018     Document Type: Article

References (42)

1. Henderson B., Kaiser F. Do reciprocal interactions between cell stress proteins and cytokines create a new intra-/extra-cellular signalling nexus?. Cell Stress Chaperones 2013, 18:685-701.
2. King Y.T., Lin C.S., Lin J.H., Lee W.C. Whole-body hyperthermia-induced thermotolerance is associated with the induction of heat shock protein 70 in mice. J Exp Biol 2002, 205(Pt 2):273-278.
3. Shi Y., Tu Z., Tang D., Zhang H., Liu M., Wang K., et al. The inhibition of LPS-induced production of inflammatory cytokines by Hsp70 involves inactivation of the NF-kappaB pathway but not the MAPK pathways. Shock 2006, 26:277-284.
4. Kregel K.C. Heat shock proteins: modifying factors in physiological stress responses and acquired thermotolerance. J Appl Physiol 2002, 92:2177-2186.
5. Glushkova O.V., Novoselova T.V., Khrenov M.O., Parfenyuk S.B., Lunin S.M., Fesenko E.E., et al. Role of heat shock protein hsp90 in formation of protective reactions in acute toxic stress. Biochemistry (Mosc) 2010, 75:702-707.
6. Kim S.O., Ono K., Han J. Apoptosis by pan-caspase inhibitors in lipopolysaccharide-activated macrophages. Am J Physiol Lung Cell Mol Physiol 2001, 281:L1095-L1105.
7. Hsu H.Y., Wen M.H. Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J Biol Chem 2002, 277:22131-22139.
8. Hsu H.Y., Wu H.L., Tan S.K., Li V.P., Wang W.T., Hsu J., et al. Geldanamycin interferes with the 90-kDa heat shock protein, affecting lipopolysaccharide-mediated interleukin-1 expression and apoptosis within macrophages. Mol Pharmacol 2007, 71:344-356.
9. Yaqoob P., Calder P.C. Cytokine production by human peripheral blood mononuclear cells: Differential sensitivity to glutamine availability. Cytokine 1998, 10:790-794.
10. Chang W.K., Yang K.D., Shaio M.F. Effect of glutamine on Th1 and Th2 cytokine responses of human peripheral blood mononuclear cells. Clin Immunol 1999, 93:294-301.
11. Wischmeyer P.E., Riehm J., Singleton K.D., Ren H., Musch M.W., Kahana M., et al. Glutamine attenuates tumor necrosis factor-alpha release and enhances heat shock protein 72 in human peripheral blood mononuclear cells. Nutrition 2003, 19:1-6.
12. Wischmeyer P.E., Kahana M., Wolfson R., Ren H., Musch M.M., Chang E.B. Glutamine induces heat shock protein and protects against endotoxin shock in the rat. J Appl Physiol 2001, 90:2403-2410.
13. Yoo C.G., Lee S., Lee C.T., Kim Y.W., Han S.K., Shim Y.S. Anti-inflammatory effect of heat shock protein induction is related to stabilization of I kappa B alpha through preventing I kappa B kinase activation in respiratory epithelial cells. J Immunol 2000, 164:5416-5423.
14. Abraham E. Why immunomodulatory therapies have not worked in sepsis?. Intensive Care Med 1999, 25:556-566.
15. Heyland D., Muscedere J., Wischmeyer P.E., Cook D., Jones G., Albert M., et al. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med 2013, 368:1489-1497. Canadian Critical Care Trials Group.
16. Carcillo J.A., Dean J.M., Holubkov R., Berger J., Meert K.L., Anand K.J., et al. The randomized comparative pediatric critical illness stress-induced immune suppression (CRISIS) prevention trial. Pediatr Crit Care Med 2012, 13:165-173. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Collaborative Pediatric Critical Care Research Network (CPCCRN).
17. Vince R.V., Oliver K., Midgley A.W., McNaughton L.R., Madden L.A. Invitro heat shock of human monocytes results in a proportional increase of inducible Hsp70 expression according to the basal content. Amino Acids 2010, 38:1423-1428.
18. Singleton K.D., Beckey V.E., Wischmeyer P.E. Glutamine prevents activation of NF-kappa B and stress kinase pathways, attenuates inflammatory cytokine release, and prevents acute respiratory distress syndrome (ARDS) following sepsis. Shock 2005, 24:583-589.
19. Coëffier M., Marion R., Ducrotté P., Déchelotte P. Modulating effect of glutamine on IL-1 beta-induced cytokine production by human gut. Clin Nutr 2003, 22:407-413.
20. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013, 41:580-637. Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup.
21. Hu S., Ciancio M.J., Lahav M., Fujiya M., Lichtenstein L., Anant S., et al. Translational inhibition of colonic epithelial heat shock proteins by IFN-gamma and TNF-alpha in intestinal inflammation. Gastroenterology 2007, 133:1893-1904.
22. Jing L., Wu Q., Wang F. Glutamine induces heat-shock protein and protects against Escherichia coli lipopolysaccharide-induced vascular hyporeactivity in rats. Crit Care 2007, 11:R34.
23. Huang Q.Q., Pope R.M. The role of glycoprotein 96 in the persistent inflammation of rheumatoid arthritis. Arch Biochem Biophys 2013, 530:1-6.
24. Cheng C.F., Sahu D., Tsen F., Zhao Z., Fan J., Kim R., et al. A fragment of secreted Hsp90-α carries properties that enable it to accelerate effectively both acute and diabetic wound healing in mice. J Clin Invest 2011, 121:4348-4361.
25. Schroeder S., Bischoff J., Lehmann L.E., Hering R., von Spiegel T., Putensen C., et al. Endotoxin inhibits heat shock protein 70 (Hsp70) expression in peripheral blood mononuclear cells of patients with severe sepsis. Intensive Care Med 1999, 25:52-57.
26. Bistrian B.R. Glutamine and antioxidants in critically ill patients. N Engl J Med 2013, 369:482.
27. Peltonen E., Pulkki K., Kirvelä O. Stimulatory effect of glutamine on human monocyte activation as measured by interleukin-6 and soluble interleukin-6 receptor release. ClinNutr 1997, 16:125-128.
28. Rohde T., MacLean D.A., Klarlund Pedersen B. Glutamine, lymphocyte proliferation and cytokine production. Scand J Immunol 1996, 44:648-650.
29. Vince R.V., Midgley A.W., Laden G., Madden L.A. The effect of hyperbaric oxygen preconditioning on heat shock protein 72 expression following invitro stress in human monocytes. Cell Stress Chaperones 2011, 16:339-343.
30. Aziz M., Jacob A., Yang W.L., Matsuda A., Wang P. Current trends in inflammatory and immunomodulatory mediators in sepsis. J Leukoc Biol 2013, 93:329-342.
31. Weaver C.T., Hatton R.D., Mangan P.R., Harrington L.E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007, 25:821-852.
32. Briassoulis G., Filippou O., Kanariou M., Hatzis T. Comparative effects of early randomized immune or non-immune-enhancing enteral nutrition on cytokine production in children with septic shock. Intensive Care Med 2005, 31:851-858.
33. Briassouli E., Briassoulis G. Glutamine randomized studies in early life: the unsolved riddle of experimental and clinical studies. Clin Dev Immunol 2012, 2012:749189.
34. Jacquier-Sarlin M.R., Fuller K., Dinh-Xuan A.T., Richard M.J., Polla B.S. Protective effects of hsp70 in inflammation. Experientia 1994, 50:1031-1038.
35. Kaiser F., Steptoe A., Thompson S., Henderson B. Monocyte cytokine synthesis in response to extracellular cell stress proteins suggests these proteins exhibit network behaviour. Cell Stress Chaperones 2014, 19:135-144.
36. Splettstoesser W.D., Schuff-Werner P. Oxidative stress in phagocytes-"the enemy within". Microsc Res Tech 2002, 57:441-455.
37. Dokladny K., Zuhl M.N., Mandell M., Bhattacharya D., Schneider S., Deretic V., et al. Regulatory coordination between two major intracellular homeostatic systems: heat shock response and autophagy. J Biol Chem 2013, 288:14959-14972.
38. Lacey J.M., Wilmore D.W. Is glutamine a conditional essential amino acid?. Nutr Rev 1990, 48:297.
39. Hou Y.C., Pai M.H., Liu J.J., Yeh S.L. Alanyl-glutamine resolves lipopolysaccharide-induced lung injury in mice by modulating the polarization of regulatory T cells and T helper 17 cells. J Nutr Biochem 2013, 24:1555-1563.
40. Oudemans-van Straaten H.M., Bosman R.J., Treskes M., van der Spoel H.J., Zandstra D.F. Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med 2001, 27:84-90.
41. Heyland D.K., Dhaliwal R. Role of glutamine supplementation in critical illness given the results of the REDOXS study. JPEN J Parenter Enteral Nutr 2013, 37:442-443.
42. Rodas P.C., Rooyackers O., Hebert C., Norberg A., Wernerman J. Glutamine and glutathione at ICU admission in relation to outcome. Clin Sci (Lond) 2012, 122:591-597.